Amundi’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,867
Closed -$864K 2160
2025
Q1
$864K Sell
19,867
-4,701
-19% -$253K ﹤0.01% 1366
2024
Q4
$1.46M Buy
24,568
+15,936
+185% +$807K ﹤0.01% 1297
2024
Q3
$357K Buy
8,632
+1,337
+18% +$63.6K ﹤0.01% 1510
2024
Q2
$328K Sell
7,295
-1,175
-14% -$55.4K ﹤0.01% 1450
2024
Q1
$371K Buy
8,470
+2,180
+35% +$95.5K ﹤0.01% 1489
2023
Q4
$235K Buy
6,290
+286
+5% +$9.96K ﹤0.01% 1594
2023
Q3
$189K Hold
6,004
﹤0.01% 1608
2023
Q2
$225K Sell
6,004
-423
-7% -$13.9K ﹤0.01% 1575
2023
Q1
$186K Buy
+6,427
New +$186K ﹤0.01% 1585

Other funds holding VCEL

Amundi's VCEL Position: Q2 2025 in Review

Amundi sold out of Vericel Corp (VCEL) in Q2 2025, closing a stake of 19,867 shares — an estimated $864K sold.

Amundi first reported a position in VCEL in Q1 2023 and held it in 9 quarters. The position peaked at $1.46M in Q4 2024. 273 funds tracked by Wall St. Rank hold VCEL as of Q2 2025.

  • Amundi reported no remaining Vericel Corp position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 19,867 Vericel Corp shares in Q2 2025, an estimated $864K.
  • Amundi first reported a position in Vericel Corp in Q1 2023 and held it in 9 quarters.
  • Amundi's Vericel Corp position peaked at $1.46M in Q4 2024.
  • 273 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.